Ventripoint Diagnostics Stock Fundamentals
| VPT Stock | CAD 0.15 0.01 6.25% |
VentriPoint Diagnostics fundamentals help investors to digest information that contributes to VentriPoint Diagnostics' financial success or failures. It also enables traders to predict the movement of VentriPoint Stock. The fundamental analysis module provides a way to measure VentriPoint Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VentriPoint Diagnostics stock.
At this time, VentriPoint Diagnostics' Total Revenue is fairly stable compared to the past year. Net Interest Income is likely to climb to about 10.6 K in 2024, whereas Other Operating Expenses is likely to drop slightly above 3.3 M in 2024. VentriPoint | Select Account or Indicator |
VentriPoint Diagnostics Company Return On Equity Analysis
VentriPoint Diagnostics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current VentriPoint Diagnostics Return On Equity | -29.73 |
Most of VentriPoint Diagnostics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VentriPoint Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
VentriPoint Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for VentriPoint Diagnostics is extremely important. It helps to project a fair market value of VentriPoint Stock properly, considering its historical fundamentals such as Return On Equity. Since VentriPoint Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of VentriPoint Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of VentriPoint Diagnostics' interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
VentriPoint Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, VentriPoint Diagnostics has a Return On Equity of -29.726. This is 24.01% higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The return on equity for all Canada stocks is notably higher than that of the company.
VentriPoint Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VentriPoint Diagnostics's current stock value. Our valuation model uses many indicators to compare VentriPoint Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VentriPoint Diagnostics competition to find correlations between indicators driving VentriPoint Diagnostics's intrinsic value. More Info.VentriPoint Diagnostics is rated second in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, VentriPoint Diagnostics' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VentriPoint Diagnostics' earnings, one of the primary drivers of an investment's value.VentriPoint Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VentriPoint Diagnostics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VentriPoint Diagnostics could also be used in its relative valuation, which is a method of valuing VentriPoint Diagnostics by comparing valuation metrics of similar companies.VentriPoint Diagnostics is currently under evaluation in return on equity category among its peers.
VentriPoint Diagnostics Current Valuation Drivers
We derive many important indicators used in calculating different scores of VentriPoint Diagnostics from analyzing VentriPoint Diagnostics' financial statements. These drivers represent accounts that assess VentriPoint Diagnostics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of VentriPoint Diagnostics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 8.9M | 5.1M | 6.7M | 42.1M | 46.3M | 48.6M | |
| Enterprise Value | 8.8M | 6.2M | 7.6M | 37.4M | 45.2M | 47.5M |
VentriPoint Fundamentals
| Return On Equity | -29.73 | ||||
| Return On Asset | -1.37 | ||||
| Operating Margin | (45.10) % | ||||
| Current Valuation | 24.83 M | ||||
| Shares Outstanding | 159.53 M | ||||
| Shares Owned By Insiders | 2.10 % | ||||
| Number Of Shares Shorted | 58.32 K | ||||
| Price To Earning | 47.50 X | ||||
| Price To Book | 7.13 X | ||||
| Price To Sales | 332.05 X | ||||
| Revenue | 49.18 K | ||||
| Gross Profit | (6.27 K) | ||||
| EBITDA | (4.86 M) | ||||
| Net Income | (4.87 M) | ||||
| Cash And Equivalents | 713.21 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 274.38 K | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (0.01) X | ||||
| Cash Flow From Operations | (3.8 M) | ||||
| Short Ratio | 0.35 X | ||||
| Earnings Per Share | (0.03) X | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 23.93 M | ||||
| Total Asset | 1.88 M | ||||
| Retained Earnings | (53.49 M) | ||||
| Working Capital | 240.09 K | ||||
| Net Asset | 1.88 M |
About VentriPoint Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VentriPoint Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VentriPoint Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VentriPoint Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 36.6 K | 34.7 K | |
| Total Revenue | 49.2 K | 75.5 K | |
| Cost Of Revenue | 73.4 K | 51.8 K | |
| Stock Based Compensation To Revenue | 10.03 | 10.53 | |
| Sales General And Administrative To Revenue | 57.11 | 59.96 | |
| Research And Ddevelopement To Revenue | 22.03 | 12.03 | |
| Ebit Per Revenue | (100.25) | (105.26) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.